I posted the below in another thread but will add it here as well.
I don't recall any substative update on Nuvaring recently.
Some poster on here claimed they already resubmitted required additional information without letting us know to FDA in March 2021, but I could not confirm that from an alternate source.
Apparently the response from Lisa was..... paraphrased.... "...we said we were going to do it in March and didn't think it is necessary to confirm that we have actually done it....." the gall !
If someone can confirm the above that would be great.
The best source of information was Mithra themselves and their 2020 Annual report from 20 April 2021.
https://investors.mithra.com/en/financial-information/
General Discussion Topics, page-16
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.61 |
Change
0.010(0.22%) |
Mkt cap ! $392.1M | |||
| Open | High | Low | Value | Volume |
| $4.60 | $4.67 | $4.46 | $913.9K | 200.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 842 | $4.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.65 | 1200 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |